• 105
  • 19
  • Favorite

COVID-19 vaccine vial maker Stevanato eyes $7 bln valuation in U.S. IPO

Reuters2021-07-07

July 7 (Reuters) - Italy's Stevanato Group S.p.A., a maker of glass vials for COVID-19 vaccine and other healthcare products, said on Wednesday it was seeking a valuation of over $7 billion in its U.S...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment19

  • BlueDragon
    ·2021-07-08
    Ok
    Reply
    Report
  • Sharoncpg
    ·2021-07-08
    Ok
    Reply
    Report
  • Sharoncpg
    ·2021-07-08
    Ok
    Reply
    Report
  • mizseah
    ·2021-07-08
    Well done its good news
    Reply
    Report
  • Moon168
    ·2021-07-08
    [Cry] [Cry] 
    Reply
    Report
  • carrotman
    ·2021-07-08
    Can they still make it? Considering a few vaccines are already in the market.
    Reply
    Report
    Fold Replies
    • Rteo
      Late To Market
      2021-07-08
      Reply
      Report
  • Philipoo
    ·2021-07-08
    Wow ? 
    Reply
    Report
  • Sunmi
    ·2021-07-08
    Vials order leadtime was approx 12 months during first half of 2020 last year.  In demand.
    Reply
    Report
  • Terry_Tey
    ·2021-07-08
    ???
    Reply
    Report
  • addyloh
    ·2021-07-07
    Pls like
    Reply
    Report
  • evwaeng
    ·2021-07-07
    vaccine mkt saturated 
    Reply
    Report
  • SherryVJ
    ·2021-07-07
    Tell me your opinion about this news...
    Reply
    Report
    Fold Replies
    • Sunmi
      Vials order leadtime was approx 12 mths in early 2020. some claim that vaccines mkt r saturated but vaccine demand is still high hence if stock valuation is reasonable, it will be worth to look into.
      2021-07-08
      Reply
      Report
  • kiraro
    ·2021-07-07
    Latest
    Reply
    Report
  • miyakos
    ·2021-07-07
    Latest
    Reply
    Report
    Fold Replies
  • Alfred1007
    ·2021-07-07
    Wow..it worth 7 billion
    Reply
    Report
    Fold Replies
  • DandanC
    ·2021-07-07
    Ok
    Reply
    Report
  • Anni001
    ·2021-07-07
    Please help like and commentThank you [微笑] 
    Reply
    Report
    Fold Replies
    • super7white
      like and comment
      2021-07-07
      Reply
      Report
  • Wpeiro87
    ·2021-07-07
    Like and comment
    Reply
    Report
    Fold Replies
    • Anni001
      Please comment like and comment back too
      2021-07-07
      Reply
      Report
  • SNee
    ·2021-07-07
    [微笑] 
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial